Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Gavras

Showing results (271-280 of 312) with videos related to

Pageof 32
Sort By:
The Journal of Infectious Diseases|December 1, 1972
Effect of furosemide on antibiotic-induced renal damage in ratsD H Lawson, R F Macadam, M H Singh, et al.
Circulation Research|February 1, 1975
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changesH Gavras, H R Brunner, J H Laragh, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1995
Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive ratsJ A Haefliger, G Bergonzelli, G Waeber, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertensionH R Brunner, H Gavras, B Waeber, et al.
The American Journal of Cardiology|September 20, 1973
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidoneE D Vaughan, J H Laragh, I Gavras, et al.
British Journal of Clinical Pharmacology|December 15, 2004
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981D B Brunner, G Desponds, J Biollaz, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 9, 1998
Chronic sympathetic suppression in the treatment of chronic congestive heart failureA J Manolis, C Olympios, M Sifaki, et al.
The American Journal of Medicine|January 1, 1975
The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertensionJ H Laragh, J E Sealey, F R Bühler, et al.
Annals of Internal Medicine|January 1, 1979
Converting enzyme inhibition in hypertensive emergenciesC P Tifft, H Gavras, G R Kershaw, et al.
Pageof 32

Showing results (271-280 of 312) with videos related to

Sort By:
Pageof 32
The Journal of Infectious Diseases|December 1, 1972
Effect of furosemide on antibiotic-induced renal damage in ratsD H Lawson, R F Macadam, M H Singh, et al.
Circulation Research|February 1, 1975
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changesH Gavras, H R Brunner, J H Laragh, et al.
Clinical Science (London, England : 1979)|December 1, 1981
Effects of the oral angiotensin-converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.
Hypertension (Dallas, Tex. : 1979)|November 1, 1995
Renin and angiotensin II receptor gene expression in kidneys of renal hypertensive ratsJ A Haefliger, G Bergonzelli, G Waeber, et al.
British Journal of Clinical Pharmacology|January 1, 1979
Orally active angiotensin-converting enzyme inhibitor (SO 14,225) as a treatment for essential hypertensionH R Brunner, H Gavras, B Waeber, et al.
The American Journal of Cardiology|September 20, 1973
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidoneE D Vaughan, J H Laragh, I Gavras, et al.
British Journal of Clinical Pharmacology|December 15, 2004
Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects. 1981D B Brunner, G Desponds, J Biollaz, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|October 9, 1998
Chronic sympathetic suppression in the treatment of chronic congestive heart failureA J Manolis, C Olympios, M Sifaki, et al.
The American Journal of Medicine|January 1, 1975
The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertensionJ H Laragh, J E Sealey, F R Bühler, et al.
Annals of Internal Medicine|January 1, 1979
Converting enzyme inhibition in hypertensive emergenciesC P Tifft, H Gavras, G R Kershaw, et al.
Pageof 32